Down Risk 1st Trimester

Description

Down’s Syndrome Risk Assessment – 1st Trimester Screening

The Down’s Risk: 1st Trimester Screening is a specialized test designed to assess the risk of Down’s syndrome (Trisomy 21) in an unborn baby during early pregnancy. This test is typically performed between 11 to 13 weeks + 6 days of gestation and helps in early risk assessment, allowing expecting parents to make informed healthcare decisions.

Tests Included in the Package:

1. Free Beta-hCG (Free B-hCG) – Measures the levels of beta-human chorionic gonadotropin, a key pregnancy hormone. Abnormal levels may indicate an increased risk of chromosomal abnormalities, including Down’s syndrome.
2. Pregnancy-Associated Plasma Protein-A (PAPP-A) – A placental protein that plays a crucial role in fetal development. Low levels of PAPP-A are often associated with an increased risk of chromosomal abnormalities and pregnancy complications.

Why Choose This Test?

• Early Screening for Down’s Syndrome – Helps identify the risk of Trisomy 21 in the first trimester.
• Safe & Non-Invasive – A simple blood test with no risk to the mother or baby.
• Essential for Pregnancy Monitoring – Supports doctors in early risk assessment and further diagnostic planning.
• Accurate & Reliable Testing – Conducted using advanced laboratory methods for precise results.
• Timely Results for Better Decisions – Performed within the optimal gestational period for early intervention if needed.

Who Should Take This Test?

• Pregnant women between 11 to 13 weeks + 6 days of gestation.
• Women with a family history of chromosomal abnormalities.
• Expecting mothers over the age of 35, as the risk of genetic conditions increases with maternal age.
• Women advised by their healthcare provider for early Down’s syndrome risk assessment.

Book Your Test Today!

Get peace of mind with the Down’s Risk: 1st Trimester Screening. Book your test now and take an important step toward a healthy pregnancy.